1. Home
  2. PAVS vs KPTI Comparison

PAVS vs KPTI Comparison

Compare PAVS & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paranovus Entertainment Technology Ltd.

PAVS

Paranovus Entertainment Technology Ltd.

HOLD

Current Price

$1.96

Market Cap

1.5M

Sector

Health Care

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$6.30

Market Cap

148.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAVS
KPTI
Founded
2004
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5M
148.0M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
PAVS
KPTI
Price
$1.96
$6.30
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$22.17
AVG Volume (30 Days)
5.3M
413.6K
Earning Date
08-04-2025
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,416,127.00
$142,530,000.00
Revenue This Year
N/A
$3.82
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18037.91
N/A
52 Week Low
$1.38
$3.51
52 Week High
$150.00
$10.80

Technical Indicators

Market Signals
Indicator
PAVS
KPTI
Relative Strength Index (RSI) 55.81 39.97
Support Level $1.74 $7.05
Resistance Level $3.04 $8.95
Average True Range (ATR) 0.32 0.62
MACD -0.06 -0.18
Stochastic Oscillator 23.68 1.85

Price Performance

Historical Comparison
PAVS
KPTI

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: